These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 30877436)

  • 41. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.
    Nader J; Rapino C; Gennequin B; Chavant F; Francheteau M; Makriyannis A; Duranti A; Maccarrone M; Solinas M; Thiriet N
    Neuropharmacology; 2014 Dec; 87():214-21. PubMed ID: 24709540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabinoids biology: the search for new therapeutic targets.
    Felder CC; Dickason-Chesterfield AK; Moore SA
    Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery and isolation of anandamide and other endocannabinoids.
    Hanus LO
    Chem Biodivers; 2007 Aug; 4(8):1828-41. PubMed ID: 17712821
    [No Abstract]   [Full Text] [Related]  

  • 45. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.
    Alhouayek M; Muccioli GG
    Trends Mol Med; 2012 Oct; 18(10):615-25. PubMed ID: 22917662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
    Fowler CJ
    Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from
    Nigro E; Formato M; Crescente G; Daniele A
    Molecules; 2021 May; 26(9):. PubMed ID: 34063214
    [No Abstract]   [Full Text] [Related]  

  • 48. Endocannabinoids in the central nervous system--an overview.
    Fride E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The endocannabinoid system and the brain.
    Mechoulam R; Parker LA
    Annu Rev Psychol; 2013; 64():21-47. PubMed ID: 22804774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
    Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
    Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.
    Di Marzo V
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):153-75. PubMed ID: 9630590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The critical role of the endocannabinoid system in emotional homeostasis: avoiding excess and deficiencies.
    Marco EM; Viveros MP
    Mini Rev Med Chem; 2009 Oct; 9(12):1407-15. PubMed ID: 19929814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain.
    Rangel-López E; Colín-González AL; Paz-Loyola AL; Pinzón E; Torres I; Serratos IN; Castellanos P; Wajner M; Souza DO; Santamaría A
    Neuroscience; 2015 Jan; 285():97-106. PubMed ID: 25446347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The endocannabinoid system and pain.
    Guindon J; Hohmann AG
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high.
    Chicca A; Schafroth MA; Reynoso-Moreno I; Erni R; Petrucci V; Carreira EM; Gertsch J
    Sci Adv; 2018 Oct; 4(10):eaat2166. PubMed ID: 30397641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The evolution of cannabinoid receptors in cancer.
    Pennant NM; Hinton CV
    WIREs Mech Dis; 2023; 15(4):e1602. PubMed ID: 36750231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
    De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
    Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabinoid-induced changes in respiration of brain mitochondria.
    Fišar Z; Singh N; Hroudová J
    Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.
    Justinová Z; Ferré S; Redhi GH; Mascia P; Stroik J; Quarta D; Yasar S; Müller CE; Franco R; Goldberg SR
    Addict Biol; 2011 Jul; 16(3):405-15. PubMed ID: 21054689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of essential binding domains for the endocannabinoid N-arachidonoylethanolamine (AEA) in the brain cannabinoid CB1 receptor.
    Shim JY
    PLoS One; 2021; 16(6):e0229879. PubMed ID: 34181638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.